Multiple sclerosis gene therapy using recombinant viral vectors: overexpression of IL-4, IL-10 and leukemia inhibitory factor in wharton’s jelly stem cells in the EAE mice model A Hosseini, H Estiri, HA Niaki, A Alizadeh, BA Zadeh, SMH Ghaderian, ... Cell Journal (Yakhteh) 19 (3), 361, 2017 | 26 | 2017 |
Lentiviral mediating genetic engineered mesenchymal stem cells for releasing IL-27 as a gene therapy approach for autoimmune diseases S Hajizadeh-Sikaroodi, A Hosseini, A Fallah, H Estiri, Z Noormohammadi, ... Cell Journal (Yakhteh) 16 (3), 255, 2014 | 19 | 2014 |
Selective β2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-Epac H Mostafavi, M Khaksarian, MT Joghataei, M Soleimani, G Hassanzadeh, ... Molecular Medicine Reports 9 (6), 2405-2410, 2014 | 17 | 2014 |
Efficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor model A Kenarkoohi, M Soleimani, T Bamdad, H Soleimanjahi, H Estiri, ... Iranian journal of cancer prevention 7 (4), 225, 2014 | 16 | 2014 |
Lentiviral mediated overexpression of NGF in adipose-derived stem cells A Alizadeh, M Soleimani, J Ai, A Fallah, SJ Hashemian, H Estiri, ... Clon Transgen 4 (3), 142, 2015 | 13 | 2015 |
Stable knockdown of adenosine kinase by lentiviral anti-ADK miR-shRNAs in Wharton’s Jelly stem cells H Estiri, A Fallah, M Soleimani, A Aliaghaei, F Karimzadeh, SB Abraki, ... Cell Journal (Yakhteh) 20 (1), 1, 2018 | 4 | 2018 |
Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy A Fallah, H Estiri, E Parrish, M Soleimani, S Zeinali, A Zadeh-Vakili Cell Journal (Yakhteh) 21 (4), 433, 2020 | 1 | 2020 |
Mouse Embryonic Stem Cells Differentiation to Neuron-like Cells H Estiri, A Fallah, M Movahedin The Neuroscience Journal of Shefaye Khatam 1 (4), 9-16, 2013 | 1 | 2013 |
Tailoring FPOX enzymes for enhanced stability and expanded substrate recognition Hajar Estiri, Shapla Bhattacharya, Jhon Alexander Rodriguez Buitrago ... Scientifc Reports, 2023 | | 2023 |